Skip to main content



27-01-2022 | Rheumatology | News | Article

Joint pain plus antibody positivity may indicate need for rheumatology referral

Classifying individuals with musculoskeletal symptoms and no clinical synovitis using anti-cyclic citrullinated peptide antibody levels and self-reported hand or foot pain may be useful to prioritize rheumatology referrals, study findings indicate.

26-01-2022 | Rheumatology | News | Article

FDA approves risankizumab for psoriatic arthritis

Click through for more information

24-01-2022 | Rheumatology | News | Article

RA-ILD ‘commonly overlooked’ despite being linked to increased mortality risk

Interstitial lung disease affects a substantial proportion of patients with rheumatoid arthritis and is associated with reduced survival, but the condition is overlooked by clinicians, suggest results from a population-based study.

20-01-2022 | Rheumatology | News | Article

Rituximab-treated patients with ANCA-associated vasculitis may not respond to third COVID-19 vaccine dose

A third dose of the Pfizer–BioNTech vaccine gives rise to a neutralizing antibody response in the majority of people with ANCA-associated vasculitis, but those treated with rituximab are unlikely to respond, researchers report.

20-01-2022 | Rheumatology | News | Article

Similar response to heterologous vs homologous COVID-19 booster jab in rituximab-treated patients

It is possible for rituximab-treated patients with no response to two mRNA vaccines against SARS-CoV-2 to respond to a third dose, with similar response rates among those switching to a vector vaccine and those given a third dose of the same vaccine, research suggests.

19-01-2022 | Rheumatology | News | Article

Comorbidities may contribute to link between psoriatic arthritis and VTE risk

People with psoriatic arthritis have an increased risk for venous thromboembolism relative to the general population, and this association is likely to be related to underlying comorbidities, research suggests.

17-01-2022 | Rheumatology | News | Article

Weight gain during glucocorticoid use may signal treatment success in giant cell arteritis

Cumulative prednisone dose and effective disease control are both associated with increased BMI among patients with giant cell arteritis, post-hoc analysis of the GiACTA trial suggests.

14-01-2022 | Rheumatology | News | Article

JAK inhibitors may increase cholesterol in people with RA

Treatment with any of the five JAK inhibitors approved for use in rheumatoid arthritis in the USA, Europe, or Japan may lead to an increase in serum cholesterol levels, suggest results of a systematic review and network meta-analysis.

13-01-2022 | Rheumatology | News | Article

NICE recommends upadacitinib for some PsA patients

Click through for further information on this announcement

12-01-2022 | Rheumatology | News | Article

Primary care study suggests no benefit of duloxetine for chronic osteoarthritis pain

Adding duloxetine to usual care does not improve pain outcomes for people with chronic osteoarthritis, suggest findings from a randomized controlled trial conducted in the primary care setting.

11-01-2022 | Rheumatology | News | Article

Hip fracture risk higher during risedronate versus alendronate drug holiday

The risk for hip fracture is higher during a treatment break from risedronate than it is during a break from alendronate, study findings indicate.

10-01-2022 | Rheumatology | News | Article

B-cell threshold for COVID-19 vaccine response defined in rituximab-treated patients

Researchers have identified a minimum level of B cells in the peripheral circulation that may serve as a biomarker for response to COVID-19 vaccines among rituximab-treated patients.

07-01-2022 | Rheumatology | News | Article

Rituximab and COVID-19 vaccination: Timing may be key for antibody response

Findings from two studies suggest that among rituximab-treated patients, those with a longer time since their last infusion may be more likely to have an antibody response to vaccines against SARS-CoV-2.

06-01-2022 | Rheumatology | News | Article

Poor perinatal outcome risk evident before SLE diagnosis in African–American women

African–American women with systemic lupus erythematosus have an increased risk for delivering preterm or small for gestational age infants, even in the years immediately before their diagnosis, US study findings indicate.

05-01-2022 | Rheumatology | News | Article

Study highlights the need to avoid ‘pandemic of inactivity’ in RA patients

People in the UK with rheumatoid arthritis did less physical activity than those without during the first COVID-19 lockdown, researchers report.

04-01-2022 | Rheumatology | News | Article

Anakinra authorized for COVID-19 pneumonia in Europe

Click through for further information on this announcement

21-12-2021 | Rheumatology | News | Article

IL-16 implicated in lupus nephritis pathogenesis

Expression of the proinflammatory cytokine interleukin-16 strongly correlates with histologic activity in people undergoing treatment for lupus nephritis, shows a longitudinal study of urinary proteomic profiles.

20-12-2021 | Rheumatology | News | Article

Anifrolumab set for EMA approval for moderate-to-severe SLE

Click through for more information on this announcement

20-12-2021 | Rheumatology | News | Article

Tofacitinib given restricted FDA approval for ankylosing spondylitis

Click through for additional information on this announcement

20-12-2021 | Rheumatology | News | Article

FDA approves upadacitinib for selected psoriatic arthritis patients

Click through for more details on this expanded indication

Image Credits